 | • レポートコード：C-GIR20G3064 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「血栓溶解薬の世界市場2019年」は、グローバルにおける血栓溶解薬市場を展望するレポートです。血栓溶解薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・血栓溶解薬の市場概観 ・血栓溶解薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・血栓溶解薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・血栓溶解薬の世界市場規模 ・血栓溶解薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・血栓溶解薬のアメリカ市場規模推移 ・血栓溶解薬のカナダ市場規模推移 ・血栓溶解薬のメキシコ市場規模推移 ・血栓溶解薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・血栓溶解薬のドイツ市場規模推移 ・血栓溶解薬のイギリス市場規模推移 ・血栓溶解薬のロシア市場規模推移 ・血栓溶解薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・血栓溶解薬の日本市場規模推移 ・血栓溶解薬の中国市場規模推移 ・血栓溶解薬の韓国市場規模推移 ・血栓溶解薬のインド市場規模推移 ・血栓溶解薬の東南アジア市場規模推移 ・血栓溶解薬の南米市場分析（ブラジル、アルゼンチン等） ・血栓溶解薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・血栓溶解薬の種類別分析/販売量、売上、市場シェア（フィブリン特異的薬物、非フィブリン特異的薬物） ・血栓溶解薬の用途別分析/市場規模（病院薬局、小売薬局、電子薬局） ・血栓溶解薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・血栓溶解薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Thrombolytic Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Thrombolytic Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Thrombolytic Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Thrombolytic Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
Mochida Pharmaceutical
Taj Pharmaceuticals
Genentech
Sedico Pharmaceuticals
Roche
Eumedica
Medac
Microbix
Wulfing Pharma GmbH
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fibrin Specific Drugs
Nonfibrin-specific Drugs
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacies
Electronic Pharmacy
Table of Contents
1 Thrombolytic Drug Market Overview
1.1 Product Overview and Scope of Thrombolytic Drug
1.2 Classification of Thrombolytic Drug by Types
1.2.1 Global Thrombolytic Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Thrombolytic Drug Revenue Market Share by Types in 2018
1.2.3 Fibrin Specific Drugs
1.2.4 Nonfibrin-specific Drugs
1.3 Global Thrombolytic Drug Market by Application
1.3.1 Global Thrombolytic Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Electronic Pharmacy
1.4 Global Thrombolytic Drug Market by Regions
1.4.1 Global Thrombolytic Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Thrombolytic Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Thrombolytic Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Thrombolytic Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Thrombolytic Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Thrombolytic Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Thrombolytic Drug (2014-2024)
2 Company Profiles
2.1 Mochida Pharmaceutical
2.1.1 Business Overview
2.1.2 Thrombolytic Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mochida Pharmaceutical Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Taj Pharmaceuticals
2.2.1 Business Overview
2.2.2 Thrombolytic Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Taj Pharmaceuticals Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Genentech
2.3.1 Business Overview
2.3.2 Thrombolytic Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Genentech Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sedico Pharmaceuticals
2.4.1 Business Overview
2.4.2 Thrombolytic Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sedico Pharmaceuticals Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Thrombolytic Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eumedica
2.6.1 Business Overview
2.6.2 Thrombolytic Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eumedica Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Medac
2.7.1 Business Overview
2.7.2 Thrombolytic Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medac Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Microbix
2.8.1 Business Overview
2.8.2 Thrombolytic Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Microbix Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
2.9 Wulfing Pharma GmbH
2.9.1 Business Overview
2.9.2 Thrombolytic Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Wulfing Pharma GmbH Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Thrombolytic Drug Market Competition, by Players
3.1 Global Thrombolytic Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Thrombolytic Drug Players Market Share
3.2.2 Top 10 Thrombolytic Drug Players Market Share
3.3 Market Competition Trend
4 Global Thrombolytic Drug Market Size by Regions
4.1 Global Thrombolytic Drug Revenue and Market Share by Regions
4.2 North America Thrombolytic Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Thrombolytic Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Thrombolytic Drug Revenue and Growth Rate (2014-2019)
4.5 South America Thrombolytic Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Thrombolytic Drug Revenue and Growth Rate (2014-2019)
5 North America Thrombolytic Drug Revenue by Countries
5.1 North America Thrombolytic Drug Revenue by Countries (2014-2019)
5.2 USA Thrombolytic Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Thrombolytic Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Thrombolytic Drug Revenue and Growth Rate (2014-2019)
6 Europe Thrombolytic Drug Revenue by Countries
6.1 Europe Thrombolytic Drug Revenue by Countries (2014-2019)
6.2 Germany Thrombolytic Drug Revenue and Growth Rate (2014-2019)
6.3 UK Thrombolytic Drug Revenue and Growth Rate (2014-2019)
6.4 France Thrombolytic Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Thrombolytic Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Thrombolytic Drug Revenue by Countries
7.1 Asia-Pacific Thrombolytic Drug Revenue by Countries (2014-2019)
7.2 China Thrombolytic Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Thrombolytic Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Thrombolytic Drug Revenue and Growth Rate (2014-2019)
7.5 India Thrombolytic Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
8 South America Thrombolytic Drug Revenue by Countries
8.1 South America Thrombolytic Drug Revenue by Countries (2014-2019)
8.2 Brazil Thrombolytic Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Thrombolytic Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Thrombolytic Drug by Countries
9.1 Middle East and Africa Thrombolytic Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Thrombolytic Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Thrombolytic Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Thrombolytic Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Thrombolytic Drug Revenue and Growth Rate (2014-2019)
10 Global Thrombolytic Drug Market Segment by Type
10.1 Global Thrombolytic Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Thrombolytic Drug Market Forecast by Type (2019-2024)
10.3 Fibrin Specific Drugs Revenue Growth Rate (2014-2024)
10.4 Nonfibrin-specific Drugs Revenue Growth Rate (2014-2024)
11 Global Thrombolytic Drug Market Segment by Application
11.1 Global Thrombolytic Drug Revenue Market Share by Application (2014-2019)
11.2 Thrombolytic Drug Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Electronic Pharmacy Revenue Growth (2014-2019)
12 Global Thrombolytic Drug Market Size Forecast (2019-2024)
12.1 Global Thrombolytic Drug Market Size Forecast (2019-2024)
12.2 Global Thrombolytic Drug Market Forecast by Regions (2019-2024)
12.3 North America Thrombolytic Drug Revenue Market Forecast (2019-2024)
12.4 Europe Thrombolytic Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Thrombolytic Drug Revenue Market Forecast (2019-2024)
12.6 South America Thrombolytic Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Thrombolytic Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Thrombolytic Drug Picture
Table Product Specifications of Thrombolytic Drug
Table Global Thrombolytic Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Thrombolytic Drug Revenue Market Share by Types in 2018
Figure Fibrin Specific Drugs Picture
Figure Nonfibrin-specific Drugs Picture
Table Global Thrombolytic Drug Revenue (Million USD) by Application (2014-2024)
Figure Thrombolytic Drug Revenue Market Share by Applications in 2018
Figure Hospital Pharmacy Picture
Figure Retail Pharmacies Picture
Figure Electronic Pharmacy Picture
Table Global Market Thrombolytic Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Thrombolytic Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Thrombolytic Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Thrombolytic Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Thrombolytic Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Thrombolytic Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Thrombolytic Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table Mochida Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Mochida Pharmaceutical Thrombolytic Drug Type and Applications
Table Mochida Pharmaceutical Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Thrombolytic Drug Type and Applications
Table Taj Pharmaceuticals Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Thrombolytic Drug Type and Applications
Table Genentech Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Sedico Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sedico Pharmaceuticals Thrombolytic Drug Type and Applications
Table Sedico Pharmaceuticals Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Thrombolytic Drug Type and Applications
Table Roche Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Eumedica Basic Information, Manufacturing Base and Competitors
Table Eumedica Thrombolytic Drug Type and Applications
Table Eumedica Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Medac Basic Information, Manufacturing Base and Competitors
Table Medac Thrombolytic Drug Type and Applications
Table Medac Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Microbix Basic Information, Manufacturing Base and Competitors
Table Microbix Thrombolytic Drug Type and Applications
Table Microbix Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Wulfing Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table Wulfing Pharma GmbH Thrombolytic Drug Type and Applications
Table Wulfing Pharma GmbH Thrombolytic Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Thrombolytic Drug Revenue (Million USD) by Players (2014-2019)
Table Global Thrombolytic Drug Revenue Share by Players (2014-2019)
Figure Global Thrombolytic Drug Revenue Share by Players in 2017
Figure Global Thrombolytic Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Thrombolytic Drug Revenue Market Share in 2018
Figure Global Top 10 Players Thrombolytic Drug Revenue Market Share in 2018
Figure Global Thrombolytic Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Thrombolytic Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Thrombolytic Drug Revenue Market Share by Regions (2014-2019)
Figure Global Thrombolytic Drug Revenue Market Share by Regions (2014-2019)
Figure Global Thrombolytic Drug Revenue Market Share by Regions in 2018
Figure North America Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Europe Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure South America Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Table North America Thrombolytic Drug Revenue by Countries (2014-2019)
Table North America Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure North America Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure North America Thrombolytic Drug Revenue Market Share by Countries in 2018
Figure USA Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Canada Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Table Europe Thrombolytic Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Thrombolytic Drug Revenue Market Share by Countries in 2018
Figure Germany Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure UK Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure France Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Russia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Italy Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Thrombolytic Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Thrombolytic Drug Revenue Market Share by Countries in 2018
Figure China Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Japan Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Korea Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure India Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Table South America Thrombolytic Drug Revenue by Countries (2014-2019)
Table South America Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure South America Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure South America Thrombolytic Drug Revenue Market Share by Countries in 2018
Figure Brazil Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Thrombolytic Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Thrombolytic Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Thrombolytic Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure UAE Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Thrombolytic Drug Revenue and Growth Rate (2014-2019)
Table Global Thrombolytic Drug Revenue (Million USD) by Type (2014-2019)
Table Global Thrombolytic Drug Revenue Share by Type (2014-2019)
Figure Global Thrombolytic Drug Revenue Share by Type (2014-2019)
Figure Global Thrombolytic Drug Revenue Share by Type in 2018
Table Global Thrombolytic Drug Revenue Forecast by Type (2019-2024)
Figure Global Thrombolytic Drug Market Share Forecast by Type (2019-2024)
Figure Global Fibrin Specific Drugs Revenue Growth Rate (2014-2019)
Figure Global Nonfibrin-specific Drugs Revenue Growth Rate (2014-2019)
Table Global Thrombolytic Drug Revenue by Application (2014-2019)
Table Global Thrombolytic Drug Revenue Share by Application (2014-2019)
Figure Global Thrombolytic Drug Revenue Share by Application (2014-2019)
Figure Global Thrombolytic Drug Revenue Share by Application in 2018
Table Global Thrombolytic Drug Revenue Forecast by Application (2019-2024)
Figure Global Thrombolytic Drug Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Electronic Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Thrombolytic Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Thrombolytic Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Thrombolytic Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Thrombolytic Drug Revenue Market Forecast (2019-2024)
Figure Europe Thrombolytic Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Thrombolytic Drug Revenue Market Forecast (2019-2024)
Figure South America Thrombolytic Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Thrombolytic Drug Revenue Market Forecast (2019-2024)
血栓溶解療法の世界市場 2019年版：種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル閉塞、急性虚血性脳卒中） Scope of the Report: The global Thrombolytic Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also…- 世界のスニチニブ薬市場予測（～2024年）：企業別、地域別、種類・用途別 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
- 世界のアンブリセンタン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx mil…
- 世界のデシタビン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Scope of the Report: The glob…
- 世界のシクロベンザプリン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…